Delivery Order SPE2DB20D2014-SPE2DB25FB83W
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$30K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,241.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a diabetes medication, with a performance period extending to April 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $4,167.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Jardiance 10 mg tablet, a diabetes treatment. It is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,758.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a firm fixed-price, delivery order contract with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
This federal contract award, valued at $4,559.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 21, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug...
This federal contract award, valued at $15,633.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 24, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug...
This federal contract award, valued at $22,694.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $15,779.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order awarded under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is valued at $999,999,999 and runs through November 2026. The contract covers the delivery of Jardiance 25 mg tablets, a medication used for diabetes management, to support...
This federal contract award, valued at $10,735.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,013,835 units of the diabetes medication Jardiance 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award, valued at $12,468.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used for the treatment of diabetes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $14,528.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Jardiance 10 mg tablets, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....